-
2022-502059-79-00
6
Ischemic stroke or transient ischemic attack
-
2022-502779-40-99
5
Primary prevention of atherosclerotic cardiovascular disease (ASCVD)
-
2025-524057-13-00
5
Achilles tendinopathy
-
2025-524229-41-00
5
Triple negative breast cancer
-
2024-517410-15-01
5
2025-01-14
Rectal cancer
-
2025-523717-29-00
5
2026-04-28
HFpEF or HFmrEF and obesity
-
2025-522960-34-00
5
2026-02-09
Established cardiovascular disease
-
2024-516036-94-00
9
2025-08-12
Metastatic castrate resistant prostate cancer - mCRPC
-
2024-519354-36-00
6
2025-08-01
Polycystic ovary syndrome (PCOS)
-
2023-510294-34-00
5
2025-06-12
small lymphocytic lymphoma (SLL)
-
2024-515445-42-00
5
2025-03-24
Node-positive, Estrogen Receptor-positive, HER2-negative, Early Breast
-
2024-514281-39-00
5
2025-02-14
Metastatic Squamous Non-small Cell Lung Cancer Whose Tumors Express PD
-
2024-515008-38-00
5
2025-02-14
Metastatic Non-squamous Non-small Cell Lung Cancer Whose Tumors Expres
-
2024-511359-16-00
5
2025-01-17
Osteoarthritis
-
2023-510109-16-00
4
2025-01-06
Acute Respiratory Distress Syndrome (ARDS) Due to Pneumonia or other I
-
2023-507489-20-00
6
2024-12-10
Statin-intolerance
-
2023-507776-42-00
5
2024-11-14
Non-small cell lung cancer
-
2023-506115-17-00
5
2024-10-14
Metastatic Colorectal Cancer
-
2024-516195-15-00
5
2024-09-10
Advanced NSCLC
-
2023-508586-33-00
5
2024-05-14
multiple myeloma
-
2022-500305-40-00
9
2024-04-10
Small Lymphocytic Lymphoma
-
2023-505220-57-03
5
2022-05-09
Predicted severe acute pancreatitis
-
2023-505438-85-00
5
2022-01-12
Acute myocardial infarction (AMI)
-
2023-505449-18-00
4
2020-07-23
Patients with relapsed CLL